UNSPSC 51182021: Bolasterone

This classification denotes an anabolic steroid with the molecular formula C21H32O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T7ZM08F7FU, chemically known as 17beta-hydroxy-7alpha,17-dimethylandrost-4-en-3-one but generally known as bolasterone, which bears US NIH Compound Identifier 102146. European Medicines Agency schedules Bolasterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05867MIG.

UNSPSC 51182021 Bolasterone, a Commodity code, designates a specific anabolic steroid pharmaceutical product, but state and local procurement activity under this code reflects broader pharmaceutical supply agreements rather than bolasterone procurement in isolation. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP posted in January 2026 targets manufacturers of generic multi-source pharmaceuticals and over-the-counter products distributed across participating state and local government facilities in Minnesota, Oregon, and other member jurisdictions. State and local governments buying under this code procure pharmaceutical products through cooperative purchasing vehicles that bundle multiple drugs and OTC items, requiring vendors to maintain compliance with current Good Manufacturing Practices, the Drug Supply Chain Security Act, and FDA requirements while supplying through authorized wholesalers with established chargeback systems.

MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary issuing body for recent activity under this code, reflecting multistate cooperative purchasing rather than single-jurisdiction procurement. The January 2026 RFP requires proposals by March 26, 2026, with awarded vendors effective July 1, 2026, and evaluation weighted heavily toward price competitiveness (75 percent) with secondary weight on fixed pricing, compliance with administrative data formats, EDI capability, and administrative fee structure. Vendors must maintain commercial general liability insurance of $5,000,000, network security liability of $2,000,000, and professional liability of $2,000,000, with performance penalties ranging from $200 to $1,500 per violation. The contract term runs two years for new responders with optional extensions, while incumbent vendors align with existing agreement expiration through June 30, 2028. No specific set-aside designations or disadvantaged-enterprise restrictions are identified in the available documentation.